Newsroom

Newsroom

NeoGenomics Appoints David Perez, Industry Veteran and Former Terumo BCT CEO, to Its Board of Directors

Press Release
Read More

Lite Paper: Real-World PD-L1 Testing Data Provides Insight into the Evolving Immuno-oncology Landscape

Blog
Read More

A single-tube NGS assay for simultaneous detection of DNA and RNA biomarkers as a comprehensive solution for clinical management and guiding therapeutic intervention of Ph-like ALL patients

Literature
Read More

Case Study: How Pharma Uses NeoGenomics Real-World Oncology Data to Accelerate Biomarker Adoption and Commercial Launch

Blog
Read More

The Breakroom Video Series

Blog
Read More

NeoGenomics Provides Update on MolDX Submission for CRC and RaDaR(TM) Commercial Launch

Press Release
Read More

Taking Spatial Toward the Clinic: DeciBio’s Q&A with Sandy Au of NeoGenomics

Blog
Read More

Is IHC going to exhaust our archival blocks the way single gene testing used to?

Blog
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients